Literature DB >> 19761736

Biogeographical origin and varicella risk in the adult immigration population in Catalonia, Spain (2004-2006).

L Valerio1, J M Escribá, J Fernández-Vázquez, C Roca, J Milozzi, L Solsona, I Molina.   

Abstract

Immigrants to the European Union may have a higher susceptibility to varicella-zoster virus primo-infection than the indigenous population. There is no evidence as yet that this is caused by genetic or social factors. Therefore, susceptibility could be due to a lesser transmission of the virus in their ecosystems of origin. A multicentre observational study was performed from July 2004 to June 2006 in four primary healthcare centres in Catalonia, Spain, monitoring varicella incidences and comparing standardised incidence rates and standardised rate ratios among different populations classified according to their biogeographical origin (holarctic, Asian paleotropical, African paleotropical or neotropical). Overall, 516 varicella cases were recorded. The standardised incidence rates per 1,000 inhabitants per year were: holarctic: 2.17 (95% confidence interval (CI): 1.95-2.39); autochthonous 2.26 (95% CI: 2.03-2.49); immigrants 3.59 (95% CI: 2.92-4.26); neotropical 4.50 (95% CI: 3.28-5.71); non-holarctic 5.38 (95% CI: 4.27-6.14); Asian paleotropical 7.03 (95% CI: 4.77-9.28); and African paleotropical 7.05 (95% CI: 1.12-23.58). The difference to the autochthonous population was greatest in immigrants of neotropical origin (standardised rate ratio = 2.07 (95% CI: 1.61-2.64) or 4.5 excess cases per 1,000 inhabitants per year) and Asian paleotropical origin (standardised rate ratio = 3.24 (95% CI: 2.47-4.11) or 9.6 excess cases per 1,000 inhabitants per year). Biogeographical origin may therefore account for the vulnerability of certain immigrant populations to varicella, in particular those from Asian paleotropical (Indostan and Southeast Asia) and neotropical (South America and the Caribbean) ecosystems. Vaccination of immigrants at high risk (fertile women, healthcare workers) could be recommendable.

Entities:  

Mesh:

Year:  2009        PMID: 19761736     DOI: 10.2807/ese.14.37.19332-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  5 in total

Review 1.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

2.  Vaccination campaign at a temporary camp for victims of the earthquake in Lorca (Spain).

Authors:  Jaime Jesús Pérez-Martín; Francisco José Romera Guirado; Yolanda Molina-Salas; Pedro José Bernal-González; José Antonio Navarro-Alonso
Journal:  Hum Vaccin Immunother       Date:  2017-03-31       Impact factor: 3.452

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 4.  Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review.

Authors:  Maria Roura; Andreu Domingo; Juan M Leyva-Moral; Robert Pool
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

5.  Prevalence of chronic infections and susceptibility to measles and varicella-zoster virus in Latin American immigrants.

Authors:  Yves Jackson; Lilian Santos; Isabelle Arm-Vernez; Anne Mauris; Hans Wolff; François Chappuis; Laurent Getaz
Journal:  Infect Dis Poverty       Date:  2016-05-11       Impact factor: 4.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.